Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
BMC Primary Care|November 18, 2025
Understanding the role and organization of health workers delivering non-communicable disease management in primary care in low- and middle-income countries: a scoping reviewArchna Gupta, Oluwasegun J Ogundele, Roxana Rabet, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 14, 2017
Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort studyM B van Ravenhorst, M W Bijlsma, M A van Houten, et al.
Osteoarthritis and Cartilage Open|January 24, 2025
CT scan-based morphometric comparison of human and canine lumbar spine generates instrumental data for intervertebral disc percutaneous surgeryN Gavira, C Decante, N Bouhsina, et al.
Nucleic Acids Research|February 9, 2022
Barcode fusion genetics-protein-fragment complementation assay (BFG-PCA): tools and resources that expand the potential for binary protein interaction discoveryDaniel Evans-Yamamoto, François D Rouleau, Piyush Nanda, et al.
HIV Clinical Trials|December 1, 2012
Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoirJ P Routy, J B Angel, J N Spaans, et al.
HIV Medicine|January 27, 2012
Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical studyJ P Routy, C L Tremblay, J B Angel, et al.
Antiviral Therapy|June 10, 2000
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis planV DeGruttola, L Dix, R D'Aquila, et al.
AIDS (London, England)|March 9, 2000
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection StudyH Salomon, M A Wainberg, B Brenner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infectionG Alter, G Hatzakis, C M Tsoukas, et al.
Antiviral Research|January 2, 2007
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtideM R Loutfy, J M Raboud, J S G Montaner, et al.
Pageof 7